Back
Bicara Therapeutics Vs. Coherent Industry Stock Comparison
Buy
62
BCAX
Bicara Therapeutics
Last Price:
$13.06
Seasonality Move:
--
Sell
42
COHR
Coherent
Last Price:
$71.51
Seasonality Move:
5%
Buy
62
Bicara Therapeutics (BCAX)
is a Buy
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $13.03. The Score for BCAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Coherent (COHR)
is a Sell
Is Coherent a Buy, Sell or Hold?
-
COHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $13.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.
COHR Stock Price Chart
BCAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 47.52 | Sell |
| Chaikin Money Flow: | -917301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.38 - 14.44) | Sell |
| Bollinger Bands (100): | (12.48 - 20.56) | Sell |
COHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.31 | Buy |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | 762666 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.5 - 80.26) | Buy |
| Bollinger Bands (100): | (78.79 - 104.93) | Sell |
BCAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.99 | Buy |
| 20-day SMA: | 13.44 | Sell |
| 50-day SMA: | 13.01 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 13.24 | Sell |
| 20-day EMA: | 13.34 | Sell |
| 50-day EMA: | 13.82 | Sell |
| 200-day EMA: | 11.26 | Buy |
COHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.47 | Buy |
| 20-day SMA: | 69.89 | Buy |
| 50-day SMA: | 82.79 | Sell |
| 200-day SMA: | 85.09 | Sell |
| 8-day EMA: | 46.43 | Buy |
| 20-day EMA: | 23.98 | Buy |
| 50-day EMA: | 10.72 | Buy |
| 200-day EMA: | 2.84 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.
Coherent Earnings Growth & COHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.01 per share, an increase this year of $1.80 per share, and an increase next year of $0.96 per share.
Bicara Therapeutics Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Coherent Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||